"10.1371_journal.pmed.1001647","plos medicine","2014-05-20T00:00:00Z","Claudia Langenberg; Stephen J Sharp; Paul W Franks; Robert A Scott; Panos Deloukas; Nita G Forouhi; Philippe Froguel; Leif C Groop; Torben Hansen; Luigi Palla; Oluf Pedersen; Matthias B Schulze; Maria-Jose Tormo; Eleanor Wheeler; Claudia Agnoli; Larraitz Arriola; Aurelio Barricarte; Heiner Boeing; Geraldine M Clarke; Françoise Clavel-Chapelon; Eric J Duell; Guy Fagherazzi; Rudolf Kaaks; Nicola D Kerrison; Timothy J Key; Kay Tee Khaw; Janine Kröger; Martin Lajous; Andrew P Morris; Carmen Navarro; Peter M Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; J Ramón Quirós; Olov Rolandsson; Carlotta Sacerdote; María-José Sánchez; Nadia Slimani; Annemieke M W Spijkerman; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Inês Barroso; Mark I McCarthy; Elio Riboli; Nicholas J Wareham","Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom; Lund University, Malmö, Sweden; Umeå University, Umeå, Sweden; The Wellcome Trust Sanger Institute, Cambridge, United Kingdom; Imperial College London, London, United Kingdom; University Hospital Scania, Malmö, Sweden; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Faculty of Health Science, University of Aarhus, Aarhus, Denmark; Institute of Biomedical Science, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany; Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Department of Health and Social Sciences, Universidad de Murcia, Spain; Epidemiology and Prevention Unit, Milan, Italy; Public Health Division of Gipuzkoa, San Sebastian, Spain; Instituto de Investigación Sanitaria BioDonostia, Basque Government, San Sebastian, Spain; Navarre Public Health Institute, Pamplona, Spain; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Inserm, CESP U1018, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain; German Cancer Research Center, Heidelberg, Germany; University of Oxford, Oxford, United Kingdom; University of Cambridge, Cambridge, United Kingdom; Center for Research on Population Health, National Institute of Public Health of Mexico, Cuernavaca, Mexico; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Unit of Preventive Medicine and Public Health, School of Medicine, University of Murcia, Murcia, Spain; Department of Public Health, Aarhus University, Aarhus, Denmark; Aalborg University Hospital, Aalborg, Denmark; Cancer Research and Prevention Institute, Florence, Italy; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy; Public Health Directorate, Asturias, Spain; Unit of Cancer Epidemiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, University of Turin, Turin, Italy; Piedmont Reference Center for Epidemiology and Cancer Prevention, Torino, Italy; Human Genetics Foundation, Torino, Italy; Andalusian School of Public Health, Granada, Spain; International Agency for Research on Cancer, Lyon, France; National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Azienda Sanitaria Provinciale di Ragusa, Ragusa, Italy; Aire Onlus, Ragusa, Italy; University Medical Center Utrecht, Utrecht, The Netherlands; University of Cambridge Metabolic Research Laboratories, Cambridge, United Kingdom; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom; School of Public Health, Imperial College London, London, United Kingdom","Conceived and designed the experiments: CL SJS PWF RAS PD NGF PF LCG TH LP OBP MBS MJT EW CA LA AB HB GMC FCC EJD GF RK NDK TJK KTK JK ML APM CN PMN KO DP SP JRQ OR CS MJS NS AMWS RT DLvdA YTvdS IB MIMC ER NJW. Performed the experiments: CL SJS PWF RAS NJW. Analyzed the data: SJS. Contributed reagents/materials/analysis tools: CL SJS PWF RAS PD NGF PF LCG TH LP OBP MBS MJT EW CA LA AB HB GMC FCC EJD GF RK NDK TJK KTK JK ML APM CN PMN KO DP SP JRQ OR CS MJS NS AMWS RT DLvdA YTvdS IB MIMC ER NJW. Wrote the first draft of the manuscript: CL NJW. Contributed to the writing of the manuscript: CL SJS PWF RAS PD NGF PF LCG TH LP OBP MBS MJT EW CA LA AB HB GMC FCC EJD GF RK NDK TJK KTK JK ML APM CN PMN KO DP SP JRQ OR CS MJS NS AMWS RT DLvdA YTvdS IB MIMC ER NJW. ICMJE criteria for authorship read and met: CL SJS PWF RAS PD NGF PF LCG TH LP OBP MBS MJT EW CA LA AB HB GMC FCC EJD GF RK NDK TJK KTK JK ML APM CN PMN KO DP SP JRQ OR CS MJS NS AMWS RT DLvdA YTvdS IB MIMC ER NJW. Agree with manuscript results and conclusions: CL SJS PWF RAS PD NGF PF LCG TH LP OBP MBS MJT EW CA LA AB HB GMC FCC EJD GF RK NDK TJK KTK JK ML APM CN PMN KO DP SP JRQ OR CS MJS NS AMWS RT DLvdA YTvdS IB MIMC ER NJW.","IB and her spouse own stock in the companies GlaxoSmithKline (GSK) and Incyte (INCY). LCG and MIM are members of the Editorial Board of PLOS Medicine.","2014","05","Claudia Langenberg","CL",47,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
